Int J Colorectal Dis30 Dec 2024
In a study involving 2,742 stage III colorectal cancer patients, high neutrophil-to-lymphocyte ratios (NLR) both before and after surgery were linked to significantly worse disease-free survival (DFS), overall survival (OS), and cancer-specific survival (CSS). Specifically, patients with consistently high NLR levels faced a 30% increased…
Int J Surg30 Dec 2024
A novel nomogram was developed to predict severe intra-abdominal adhesions prior to definitive surgery for anastomotic fistula post-small intestine resection. Analyzing data from 414 patients, five key predictors emerged: SOFA score, early-stage abdominal infection duration, preoperative albumin levels, fat area ratio, and preoperative C-reactive protein…
Tech Coloproctol30 Dec 2024
Closure of the pelvic inlet with a bladder peritoneal flap during abdominoperineal resection significantly decreased the rate of postoperative ileus due to incarceration, showing a rate of 0% versus 17% in those without closure (p=0.03). Additionally, patients with pelvic inlet closure experienced a shorter hospital…
Dig Liver Dis28 Dec 2024
French intergroup clinical practice guidelines for managing rectal adenocarcinoma were published in September 2023. The guidelines categorize treatment based on tumor stage, with specific recommendations for endoscopic and surgical excision, radical surgery, and total neoadjuvant treatment. Additionally, they emphasize rectal conservation for select small tumors…
Ann Surg Oncol26 Dec 2024
A study evaluated deep learning, radiomics, and fusion models to predict KRAS mutations in rectal cancer using endorectal ultrasound images from 304 patients. Among the models, the feature-based fusion model (dlrexpand10_fb) achieved the highest area under the receiver operating characteristic curve (AUC) of 0.896, indicating…
World J Surg26 Dec 2024
A retrospective study involving 222,583 colon cancer patients highlights the impact of Commission on Cancer (CoC) hospital accreditation on treatment quality and survival. At CoC-accredited facilities, 91.2% of patients received guideline-concordant lymphadenectomy and 81.9% received appropriate chemotherapy. Notably, risk-adjusted mortality rates were significantly reduced across…
J Surg Oncol25 Dec 2024
A predictive risk score (PRS) for lymphovascular invasion (LVI) in rectal cancer has been successfully developed, highlighting key independent predictors. Out of 55,178 patients analyzed, LVI was present in 18.9%. The PRS demonstrated an incidence of LVI of 16.3% in the low-risk group, rising to…
Intestine and Lower Gastrointestinal Tract24 Dec 2024
An international registry of 104 rectal cancer surgeries using single port robotic technology reported successful outcomes. The procedure demonstrated a 97.1% completeness in total mesorectal excision specimens and a low R1 margin rate of 3.8%. Operating time averaged 168 minutes with no intraoperative complications and…
Clin Res Hepatol Gastroenterol24 Dec 2024
The study demonstrated that triplet induction chemotherapy with folfirinox results in an objective response rate of 80% and a disease control rate of 92% in patients with synchronous metastatic rectal cancer (smrc). Analysis of 146 patients revealed that 69% of those with resectable metastases underwent…
Am J Surg23 Dec 2024
A recent systematic review and meta-analysis examined alternative colorectal anastomotic devices, finding a pooled complication rate of 9.7% in human studies. Notably, the leak rate for compression anastomoses was only 3.3%, demonstrating no variation among studies. This review included 18 studies with a total of…